COVID-19 Infections Still Occur: How Do Pregnant and Non-Pregnant Individuals Compare? A Study from the Canadian

Anick Bérard1,2,3, Odile Sheehy1, Padma Kaul4

  • 1Research Center, CHU Ste-Justine, Montreal, QC H3T 1C5, Canada.

Insights

Pregnant individuals with COVID-19 face increased risks of adverse outcomes like spontaneous abortion and prematurity. Early treatment with medications can mitigate these risks, emphasizing the need for continued surveillance during pregnancy.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Public Health

Background:

  • Over 100 million pregnant individuals globally are at risk of COVID-19.
  • Understanding COVID-19's impact on pregnancy and neonatal outcomes is crucial.

Purpose of the Study:

  • To compare severe COVID-19 prevalence in pregnant versus non-pregnant individuals of reproductive age.
  • To assess the risk of adverse pregnancy and neonatal outcomes associated with COVID-19 during gestation.

Main Methods:

  • Utilized data from the Canadian Mother-Child Cohort (February 2020-2021).
  • Included pregnant individuals with completed trimesters and non-pregnant individuals (aged 15-45) with positive COVID-19 tests.
  • Quantified associations using log-binomial regressions, categorizing severity by hospitalization.

Main Results:

  • COVID-19 in pregnancy was linked to higher risks of spontaneous abortion, gestational diabetes, prematurity, and NICU admission.
  • Maternal age was significantly lower in pregnant individuals diagnosed with COVID-19.
  • Medication treatment for COVID-19 reduced the risks of adverse outcomes.

Conclusions:

  • Severe COVID-19 is more prevalent in pregnancy and associated with increased maternal and neonatal risks.
  • Continued surveillance during pregnancy is vital for preventing adverse outcomes, especially as preventive strategies are relaxed.
  • Early medical intervention for COVID-19 in pregnant individuals can mitigate negative consequences.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...